FDA warns HIV med­i­ca­tion firm

Los Angeles Times - - Business -

The U.S. Food and Drug Ad­min­is­tra­tion has warned Gilead Sci­ences Inc. about man­u­fac­tur­ing prob­lems at the San Di­mas plant where the com­pany’s flag­ship HIV medicines and other drugs are made.

Gilead, in a reg­u­la­tory fil­ing, said the warn­ing let­ter from the agency is con­nected with an in­spec­tion of the fa­cil­ity that took place in Jan­uary and Fe­bru­ary. Gilead said it re­sponded in March to the FDA’s ob­ser­va­tions.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.